Notice names this product. VITRUVIAS THERAPEUTICS’s Thyroid Tablets is named in FDA Class I recall D-0866-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Superpotent Drug Identifying details: Lot # 504950, Exp Date: 09/30/2026.. Units affected: 1955 bottles. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Superpotent Drug
Company / brand: VITRUVIAS THERAPEUTICS recalls
Affected product: Thyroid Tablets recall status
Official ID D-0866-2026 · Official record ↗
See all VITRUVIAS THERAPEUTICS recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.